Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that Arthur Bedrosian, the company’s president and CEO, purchased 20,467 shares of Lannett Company common stock in the open market on September 9, 2011. A Form 4 was filed today reflecting the purchase of the shares.
About Lannett Company, Inc.
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of indications. For more information, visit Lannett Company’s website at
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts